Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis-Reference-Cited by-同舟云学术

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis

Published:2016 Issue:20 Volume:55 Page:2911-2916
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Iwamoto Takuya¹,Maeda Masaki¹,Hisanaga Takuro¹,Saeki Issei¹,Fujisawa Koichi¹,Matsumoto Toshihiko¹,Hidaka Isao¹,Ishikawa Tsuyoshi¹,Takami Taro¹,Sakaida Isao¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/55/20/55_55.6819/_pdf

Reference22 articles.

1. 1. El-Bokl MA, Senousy BE, El-Karmouty KZ, et al. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites. World J Gastroenterol 15: 3631-3635, 2009.

2. 2. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38: 258-266, 2003.

3. 3. Runyon BA. Historical aspects of treatment of patients with cirrhosis and ascites. Semin Liver Dis 17: 163-173, 1997.

4. 4. Assimakopoulos SF, Thomopoulos KC, Kalogeropoulou C, et al. Unilateral leg edema in a cirrhotic patient with tense ascites. World J Gastroenterol 12: 5746-5747, 2006.

5. 5. Ginès P, Wong F, Watson H, et al. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology 48: 204-213, 2008.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma renin activity predicts prognosis and liver disease-related events in liver cirrhosis patients with ascites treated by tolvaptan;Digestive Diseases;2021-07-30

2. Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan;International Journal of Molecular Sciences;2021-05-25

3. High expression of a vascular stricture‐related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long‐term survival after tolvaptan administration for liver cirrhosis;Hepatology Research;2020-12

4. Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma;European Journal of Gastroenterology & Hepatology;2020-11-30

5. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial;BMC Gastroenterology;2020-11-19